November 01, 2025
The simulators market size is projected to expand from USD 14.72 billion in 2026 to USD 25.53 billion by 2034,...
Read MoreNovember 01, 2025
The anti-aging market size is expected to rise from USD 84.4 billion in 2026 to USD 129.88 billion by 2034, gr...
Read MoreDecember 22, 2025
The U.S. behavioral health market is projected to expand from USD 101.84 billion in 2026 to USD 159.35 billion...
Read MoreNovember 01, 2025
The osteoarthritis therapeutics market size is expected to see growth from USD 11.92 billion in 2026 to USD 24...
Read MoreNovember 01, 2025
Market insights predict, the cartilage repair industry is expected to grow from USD 1.51 billion in 2024 to USD 7.32 billion by 2034, driven by a CAGR of 17.14%. The cartilage repair market is growing due to the rising geriatric population. North America’s dominance can be attributed to the rising cases of injuries in adults....
November 01, 2025
Based on market forecasts, the global heartworm treatment products market, projected at USD 1.45 billion in 2024, is expected to reach USD 2.85 billion by 2034, growing at a CAGR of 7.04% over the forecast period. The global market is propelled by the growing pet ownership and demand for awareness about heartworm treatments. The presence of well-de...
November 01, 2025
According to forecasts, the global drug-induced dyskinesia market will grow from USD 418 million in 2024 to USD 627.5 million by 2034, with an expected CAGR of 4.34%. The market is growing due to the rising prevalence of Parkinsons disease and increased long-term use of dopaminergic therapies. North America dominated the market due to the rising de...
November 01, 2025
The peptide-based weight loss medication market is expanding due to a growing health-conscious population as well as rising muscle-preserving weight loss medications. North America led the market due to the presence of a well-developed healthcare sector....
November 01, 2025
Based on market forecasts, the veterinarian care sector will expand from USD 21.87 billion in 2024 to USD 38.3 billion by 2034, experiencing a CAGR of 5.75%. Increasing pet adoption in the world is boosting the demand for veterinary services, which has driven the market growth. North America led the global market owing to the rising awareness of pr...
November 01, 2025
Market insights predict the global controlled substance industry will increase from USD 93.7 billion in 2024 to USD 157.7 billion by 2034, achieving a CAGR of 5.35%. The rising prevalence of chronic and neurological disorders is estimated to drive the growth of the market. North America led the global market owing to the advanced healthcare infrast...
November 01, 2025
Market insights predict, the intravenous immunoglobulin industry is expected to grow from USD 17.12 billion in 2024 to USD 40.78 billion by 2034, driven by a CAGR of 9.14%. The rising prevalence of immunological disorders and the increasing awareness of blood donations drive the global market. North America dominated the global market due to a robu...
November 01, 2025
Market insights predict, the brachytherapy industry is expected to grow from USD 1.04 billion in 2024 to USD 2.10 billion by 2034, driven by a CAGR of 7.27%. The market is growing due to the increasing prevalence and rising demand for targeted, minimally invasive treatment options. Additionally, advancements in brachytherapy technologies are improv...
November 01, 2025
Projections indicate that, minimally invasive surgery industry is projected to rise from USD 81.69 billion in 2024 to USD 362.43 billion by 2034, reflecting a CAGR of 16.05% over the next decade. The minimally invasive surgery market is expanding due to growing diseases as well as rising endoscopic surgeries. North America led the market due to the...
November 01, 2025
Market insights predict the global electron brachytherapy industry will increase from USD 451.36 million in 2024 to USD 1121.66 million by 2034, achieving a CAGR of 9.52%. The rising cases of cancer are driving the electron brachytherapy market. North America dominated the market due to growing clinical trials for improving cancer treatments....
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com